EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY 4.0

Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients With Tuberculous Meningitis: A 2-Center Retrospective Cohort Study

Rui Chen iD, Yaojie Shen iD, Huarui Liu, Meiji Wang, Zhentao Fei, Lu Xia iD, Dan Ye, Yang Ren, Xiaoqing Ma, Yang Yang, Meijun Liu, Xuhui Liu und 2 weitere

Clinical Infectious Diseases · 23.07.2026 · 83 (1) · e177-e184

DOI: 10.1093/cid/ciag106 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 18.02.2026. Verfasst von Rui Chen und 13 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Tuberculosis, Meningeal, Antitubercular Agents, Dexamethasone, Isoniazid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health Commission of the People's Republic of China, Science and Technology Commission of Shanghai Municipality, Shanghai Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to evaluate the effect of intrathecal (IT) administration of antituberculosis agents on functional outcomes in patients with tuberculous meningitis (TBM) and to explore its potential as a strategy to overcome the blood–brain barrier.

Methods

We retrospectively analyzed TBM patients admitted between 2012 and 2023 at Hangzhou Red Cross Hospital and Shanghai Public Health Clinical Center. Clinical data were collected during hospitalization, and functional outcomes were assessed at 3–6 months after discharge using the modified Rankin Scale (mRS). Propensity score matching (PSM) was applied to balance baseline characteristics between patients who received IT therapy and those who did not. Treatment effects were compared using the Mann–Whitney U test.

Results

A total of 533 patients with TBM were included. After PSM, 72 patients receiving IT therapy were compared with 121 matched controls. Intrathecal therapy was associated with significantly lower mRS scores at discharge compared with controls (P = .0012), suggesting that it may improve functional outcomes.

Conclusions

Intrathecal administration of isoniazid and dexamethasone may improve functional prognosis in TBM patients. These findings highlight IT therapy as a promising approach to circumvent the blood–brain barrier and warrant validation in multicenter randomized controlled trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tuberculosis, MeningealAntitubercular AgentsDexamethasoneIsoniazidHumansRetrospective StudiesFemaleMaleTreatment OutcomeAdultInjections, SpinalMiddle AgedChina

Stichwörter der Autor:innen

intrathecal treatmentmodified Rankin Scale scorepropensity score matchingtuberculous meningitis

Substanzen

Antitubercular AgentsDexamethasoneIsoniazid

Autor:innen und Institutionen

  • Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai, China.
  • Department of Pulmonary and Critical Care Medicine, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Department of Tuberculosis, Hangzhou Red Cross Hospital, Hangzhou, Zhejiang, China.
  • Department of Tuberculosis, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
  • Institute for AIDS/STD Prevention and Control, Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.
  • Tuberculosis Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

ORCID-Profile: Rui Chen, Yaojie Shen, Lu Xia

Förderung

  • National Health Commission of the People's Republic of China
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Hospital Development Center
  • SHDC
  • Guangzhou National Laboratory

Zitieren

APA

Chen, R., Shen, Y., Liu, H., Wang, M., Fei, Z., Xia, L., Ye, D., Ren, Y., Ma, X., Yang, Y., Liu, M., Liu, X., Chen, Y., & Li, F. (2026). Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients With Tuberculous Meningitis: A 2-Center Retrospective Cohort Study. Clinical Infectious Diseases, 83(1), e177-e184. https://doi.org/10.1093/cid/ciag106

Vancouver

Chen R, Shen Y, Liu H, Wang M, Fei Z, Xia L, et al. Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients With Tuberculous Meningitis: A 2-Center Retrospective Cohort Study. Clinical Infectious Diseases. 2026;83(1):e177-e184. doi:10.1093/cid/ciag106

BibTeX
@article{Chen2026,
  author = {Chen, Rui and Shen, Yaojie and Liu, Huarui and Wang, Meiji and Fei, Zhentao and Xia, Lu and Ye, Dan and Ren, Yang and Ma, Xiaoqing and Yang, Yang and Liu, Meijun and Liu, Xuhui and Chen, Yuanyuan and Li, Feng},
  title = {Intrathecal Isoniazid and Dexamethasone Therapy May Improve Outcomes in Patients With Tuberculous Meningitis: A 2-Center Retrospective Cohort Study},
  journal = {Clinical Infectious Diseases},
  year = {2026},
  volume = {83},
  number = {1},
  pages = {e177--e184},
  doi = {10.1093/cid/ciag106}
}
Kostenlos starten →